BioCentury | Sep 15, 1997
Company News

CDR, CellGenEx Inc., Xcyte deal

CDR Therapeutics Inc., Seattle, Wash. CellGenEx Inc., Chicago, Ill. Xcyte Therapies Inc., Seattle, Wash. Business: Autoimmune/Inflammation, Transplant CDR and CellGenEx merged to form Xcyte Therapies, which will develop small molecule drugs for immunology, oncology and...
BioCentury | Sep 30, 1996
Emerging Company Profile

CDR Therapeutics Inc.

CDR Therapeutics Inc. Mercer Island, Wash. Technology: Small molecule analogs of the CDR portion of antibodies Disease focus: Cancer, autoimmune diseases, transplant rejection Clinical status: Preclinical Founded: 1996 by Ron Berenson and Mark Greene Corporate...
Items per page:
1 - 2 of 2
BioCentury | Sep 15, 1997
Company News

CDR, CellGenEx Inc., Xcyte deal

CDR Therapeutics Inc., Seattle, Wash. CellGenEx Inc., Chicago, Ill. Xcyte Therapies Inc., Seattle, Wash. Business: Autoimmune/Inflammation, Transplant CDR and CellGenEx merged to form Xcyte Therapies, which will develop small molecule drugs for immunology, oncology and...
BioCentury | Sep 30, 1996
Emerging Company Profile

CDR Therapeutics Inc.

CDR Therapeutics Inc. Mercer Island, Wash. Technology: Small molecule analogs of the CDR portion of antibodies Disease focus: Cancer, autoimmune diseases, transplant rejection Clinical status: Preclinical Founded: 1996 by Ron Berenson and Mark Greene Corporate...
Items per page:
1 - 2 of 2